Department for Radiotherapy, University Hospital Essen, National Center for Tumor Diseases (NCT) West
Essen, Germany / NRW, 45147, Germany
Location status: Recruiting
NCT Number: NCT06253338
The long-term goal is to define "signatures" in the form of genomic changes through sequence analyses of genomic DNA using modern Next Generation Sequencing (NGS) methods, which
1. determine the radiation exposure of humans. 2. provide information about the exposure (dose). 3. determine the radiation quality. 4. predict the repair capacity and radiation resistance of an individual.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Essen, Germany / NRW, 45147, Germany
Location status: Recruiting
The planned research work will investigate structural changes in DNA caused by loosely ionizing and high-LET (Linear Energy Transfer) radiation as well as their attribution to double-strand break repair pathways, which will be analysed in parallel using modern microscopy methods. Our aim is to incorporate sequencing technologies into the spectrum of methods used in radiation research and radiation protection. It is important for us to consider the practical requirements of radiation protection and to extend our experimental approaches to cell types relevant to radiation protection. For this reason, we have now created a separate work program that will focus specifically on sequence analyses in irradiated human lymphocytes. The aim is to successfully transfer the experimental approaches and bioinformatic analyses established in previous experiments in human skin fibroblasts to lymphocytes. Subjects can donate blood samples on a voluntary basis at predetermined times. Only subjects without previous radiotherapy, chemotherapy, immunotherapy, targeted therapy, etc. and without a previous tumor diagnosis in the medical history and in good performance status (ECOG 0-1) will be included.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
ECOG 0/1 no prior treatment no prior cancer diagnosis thoracic or head and neck cancer
Exclusion criteria
prior treatment (chemotherapy, radiotherapy, etc.) prior cancer diagnosis
Alteration of the genome under radiotherapy
Time frame: 5 years
Radiotherapy of patients, quantitative tissue sampling, cell culture survival rate and mitotic index after predifined radiation treatment, Incidence of the sample and percentage
Time frame: 5 years
Overall Survival
Time frame: 5 years
Progression Free Survival
Time frame: 2 months to 5 years
Radiation induced changes in the genome analyzing human skin fibroblasts and lymphocytes:
translocations that permitted cell division andm mismatch repair of radiation-induced DNA damage (PCR and M-FISH), Incidence of the sample and percentage
Interested in participating?
Request InfoUniversity Hospital, Essen
Other
Optimization of Radiation Protection Through Genomic Analyses in the Analysis of Changes in Cells of the Hematopoietic System Before and During High Dose External Beam Radiotherapy
Acronym: ORtogether
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03297385
Androgen Receptor Abnormal, DNA
View Trial DetailsNCT01397136
Culture Media, DNA
Genova, GE, Italy
View Trial DetailsNCT03235427
Adenocarcinoma, Arterial Occlusive Diseases
Lake Success, New York, United States
View Trial DetailsNCT05973344
Cancer, Neoplasms
Brest, France
View Trial Details